Guardian Pharmacy Services (NYSE:GRDN) Announces Earnings Results

Guardian Pharmacy Services (NYSE:GRDN) issued its earnings results on Wednesday. The company reported $0.37 EPS for the quarter, topping the consensus estimate of $0.27 by $0.10, FiscalAI reports. Guardian Pharmacy Services had a return on equity of 30.29% and a net margin of 2.90%.The firm had revenue of $397.62 million during the quarter, compared to the consensus estimate of $390.04 million.

Guardian Pharmacy Services Stock Performance

Shares of GRDN stock traded up $0.13 on Wednesday, hitting $33.78. The company had a trading volume of 601,395 shares, compared to its average volume of 238,147. Guardian Pharmacy Services has a twelve month low of $18.50 and a twelve month high of $37.43. The firm has a market cap of $2.14 billion, a P/E ratio of 53.62 and a beta of 0.86. The stock’s 50-day moving average is $31.73 and its two-hundred day moving average is $29.29.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in GRDN. Boston Partners boosted its stake in shares of Guardian Pharmacy Services by 418.7% in the 3rd quarter. Boston Partners now owns 1,046,877 shares of the company’s stock valued at $26,922,000 after purchasing an additional 845,048 shares during the last quarter. Loomis Sayles & Co. L P acquired a new position in Guardian Pharmacy Services in the fourth quarter valued at $19,126,000. Millennium Management LLC boosted its position in Guardian Pharmacy Services by 725.2% during the third quarter. Millennium Management LLC now owns 342,038 shares of the company’s stock valued at $8,972,000 after acquiring an additional 300,587 shares during the last quarter. Valiant Capital Management L.P. boosted its position in Guardian Pharmacy Services by 15.8% during the fourth quarter. Valiant Capital Management L.P. now owns 1,232,463 shares of the company’s stock valued at $37,085,000 after acquiring an additional 167,741 shares during the last quarter. Finally, Bank of America Corp DE grew its holdings in Guardian Pharmacy Services by 323.3% during the 3rd quarter. Bank of America Corp DE now owns 206,143 shares of the company’s stock worth $5,407,000 after acquiring an additional 157,440 shares during the period.

Analyst Upgrades and Downgrades

Several brokerages recently issued reports on GRDN. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Guardian Pharmacy Services in a report on Monday, December 29th. Truist Financial boosted their price target on Guardian Pharmacy Services from $30.00 to $34.00 and gave the stock a “buy” rating in a report on Friday, November 14th. Stephens raised their price objective on shares of Guardian Pharmacy Services from $35.00 to $36.00 and gave the company an “overweight” rating in a report on Wednesday, January 14th. Finally, Wall Street Zen upgraded shares of Guardian Pharmacy Services from a “buy” rating to a “strong-buy” rating in a research report on Monday, November 17th. Four research analysts have rated the stock with a Buy rating and one has given a Hold rating to the company’s stock. Based on data from MarketBeat, Guardian Pharmacy Services has an average rating of “Moderate Buy” and a consensus target price of $32.00.

Guardian Pharmacy Services Company Profile

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes. The company’s Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; and GuardianShield Programs for LTCFs.